These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 31589320)

  • 21. Modeling colorectal cancer using CRISPR-Cas9-mediated engineering of human intestinal organoids.
    Matano M; Date S; Shimokawa M; Takano A; Fujii M; Ohta Y; Watanabe T; Kanai T; Sato T
    Nat Med; 2015 Mar; 21(3):256-62. PubMed ID: 25706875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clustered Regularly Interspaced Short Palindromic Repeats/Cas9 Gene Editing Technique in Xenotransplantation.
    Naeimi Kararoudi M; Hejazi SS; Elmas E; Hellström M; Naeimi Kararoudi M; Padma AM; Lee D; Dolatshad H
    Front Immunol; 2018; 9():1711. PubMed ID: 30233563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted Pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancer.
    Wang S; Liu JC; Kim D; Datti A; Zacksenhaus E
    Breast Cancer Res; 2016 Jan; 18(1):9. PubMed ID: 26781438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of human-induced pluripotent stem cells carrying homozygous RB1 gene deletion.
    Deng X; Iwagawa T; Fukushima M; Watanabe S
    Genes Cells; 2020 Jul; 25(7):510-517. PubMed ID: 32277725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Divergent Routes toward Wnt and R-spondin Niche Independency during Human Gastric Carcinogenesis.
    Nanki K; Toshimitsu K; Takano A; Fujii M; Shimokawa M; Ohta Y; Matano M; Seino T; Nishikori S; Ishikawa K; Kawasaki K; Togasaki K; Takahashi S; Sukawa Y; Ishida H; Sugimoto S; Kawakubo H; Kim J; Kitagawa Y; Sekine S; Koo BK; Kanai T; Sato T
    Cell; 2018 Aug; 174(4):856-869.e17. PubMed ID: 30096312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficient genetic editing of human intestinal organoids using ribonucleoprotein-based CRISPR.
    Skoufou-Papoutsaki N; Adler S; D'Santos P; Mannion L; Mehmed S; Kemp R; Smith A; Perrone F; Nayak K; Russell A; Zilbauer M; Winton DJ
    Dis Model Mech; 2023 Oct; 16(10):. PubMed ID: 37772705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo genome-editing screen identifies tumor suppressor genes that cooperate with Trp53 loss during mammary tumorigenesis.
    Heitink L; Whittle JR; Vaillant F; Capaldo BD; Dekkers JF; Dawson CA; Milevskiy MJG; Surgenor E; Tsai M; Chen HR; Christie M; Chen Y; Smyth GK; Herold MJ; Strasser A; Lindeman GJ; Visvader JE
    Mol Oncol; 2022 Mar; 16(5):1119-1131. PubMed ID: 35000262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CRISPR/Cas9-mediated gene knockout of NANOG and NANOGP8 decreases the malignant potential of prostate cancer cells.
    Kawamura N; Nimura K; Nagano H; Yamaguchi S; Nonomura N; Kaneda Y
    Oncotarget; 2015 Sep; 6(26):22361-74. PubMed ID: 26087476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studying Kidney Disease Using Tissue and Genome Engineering in Human Pluripotent Stem Cells.
    Garreta E; González F; Montserrat N
    Nephron; 2018; 138(1):48-59. PubMed ID: 28988229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pooled In Vitro and In Vivo CRISPR-Cas9 Screening Identifies Tumor Suppressors in Human Colon Organoids.
    Michels BE; Mosa MH; Streibl BI; Zhan T; Menche C; Abou-El-Ardat K; Darvishi T; Członka E; Wagner S; Winter J; Medyouf H; Boutros M; Farin HF
    Cell Stem Cell; 2020 May; 26(5):782-792.e7. PubMed ID: 32348727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reverse-engineering the serrated neoplasia pathway using CRISPR-Cas9.
    Bleijenberg A; Dekker E
    Nat Rev Gastroenterol Hepatol; 2018 Sep; 15(9):522-524. PubMed ID: 29875470
    [No Abstract]   [Full Text] [Related]  

  • 32. CRISPR-Cas9 for cancer therapy: Opportunities and challenges.
    Chen M; Mao A; Xu M; Weng Q; Mao J; Ji J
    Cancer Lett; 2019 Apr; 447():48-55. PubMed ID: 30684591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p53 Throws CRISPR a Curve.
    Carroll D
    Trends Pharmacol Sci; 2018 Sep; 39(9):783-784. PubMed ID: 30006230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent advances in CRISPR/Cas9 mediated genome editing in Bacillus subtilis.
    Hong KQ; Liu DY; Chen T; Wang ZW
    World J Microbiol Biotechnol; 2018 Sep; 34(10):153. PubMed ID: 30269229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nuclear Envelope Rupture Is Enhanced by Loss of p53 or Rb.
    Yang Z; Maciejowski J; de Lange T
    Mol Cancer Res; 2017 Nov; 15(11):1579-1586. PubMed ID: 28811362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [CRISPR-Cas system as molecular scissors for gene therapy].
    Heinz GA; Mashreghi MF
    Z Rheumatol; 2017 Feb; 76(1):46-49. PubMed ID: 28124743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.
    Lü Y; Cho T; Mukherjee S; Suarez CF; Gonzalez-Foutel NS; Malik A; Martinez S; Dervovic D; Oh RH; Langille E; Al-Zahrani KN; Hoeg L; Lin ZY; Tsai R; Mbamalu G; Rotter V; Ashton-Prolla P; Moffat J; Chemes LB; Gingras AC; Oren M; Durocher D; Schramek D
    Mol Syst Biol; 2024 Jun; 20(6):719-740. PubMed ID: 38580884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a CRISPR/Cas9 System for Methylococcus capsulatus
    Tapscott T; Guarnieri MT; Henard CA
    Appl Environ Microbiol; 2019 Jun; 85(11):. PubMed ID: 30926729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CRISPR: Stressed about p53?
    Foronda M; Dow LE
    Trends Mol Med; 2018 Sep; 24(9):731-733. PubMed ID: 30017531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of PTEN‑knockout (‑/‑) murine prostate cancer cells using the CRISPR/Cas9 system and comprehensive gene expression profiling.
    Takao A; Yoshikawa K; Karnan S; Ota A; Uemura H; De Velasco MA; Kura Y; Suzuki S; Ueda R; Nishino T; Hosokawa Y
    Oncol Rep; 2018 Nov; 40(5):2455-2466. PubMed ID: 30226608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.